Prudential Financial’s Immunic IMUX Stock Holding History

Prudential Financial’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,725	Closed	-$40.6K	–	2653
2023 Q1	$40.6K	Hold	2,725	–	–	﹤0.01%	2518
2022 Q4	$38.1K	Buy	+2,725	New	+$74.3K	﹤0.01%	2520

Other funds holding IMUX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Prudential Financial's IMUX Position: Q2 2023 in Review

Prudential Financial sold out of Immunic (IMUX) in Q2 2023, closing a stake of 2,725 shares — an estimated $40.6K sold.

Prudential Financial first reported a position in IMUX in Q4 2022 and held it in 2 quarters. The position peaked at $40.6K in Q1 2023. 63 funds tracked by Wall St. Rank hold IMUX as of Q2 2023.

Prudential Financial reported no remaining Immunic position as of Q2 2023 after selling out during the quarter.
Prudential Financial sold 2,725 Immunic shares in Q2 2023, an estimated $40.6K.
Prudential Financial first reported a position in Immunic in Q4 2022 and held it in 2 quarters.
Prudential Financial's Immunic position peaked at $40.6K in Q1 2023.
63 funds tracked by Wall St. Rank held Immunic as of Q2 2023.

Based on Prudential Financial's 13F filing for Q2 2023, filed 11 Aug 2023.